Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
—638.56640.21645.32638.69——
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
—213.36213.36215.79212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
—2,382.452,371.192,380.452,362.86——
PSTV:NASDAQ
Plus Therapeutics Inc
$5.95
0.00%
(0.00) 1D
Apr 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PSTV...
Mkt. cap
40.83M
Avg. vol.
475.63K
Volume
3.70K
52-wk high
$30.50
52-wk low
$2.90
EPS
-$7.19
Beta
1.03
Shares outstanding
6.86M
No. of employees
28
News stories
From sources across the web
Profile
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®. Wikipedia
About Plus Therapeutics Inc
CEO-
Employees28
Founded1996
Headquarters-
SectorBiotechnology
Websiteplustherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.06M
1.39M
1.40M
1.37M
Cost of goods sold
1.76M
1.25M
2.44M
2.94M
Cost of revenue
1.76M
1.25M
2.44M
2.94M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.84M
1.68M
3.44M
4.17M
Operating expense
2.84M
1.68M
3.44M
4.17M
Total operating expenses
4.60M
2.93M
5.88M
7.11M
Operating income
-3.54M
-1.54M
-4.48M
-5.74M
Other non operating income
-13.32M
6.66M
-
-
EBT including unusual items
-17.40M
5.15M
-4.42M
-5.71M
EBT excluding unusual items
-17.40M
5.15M
-4.42M
-5.71M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.40M
5.15M
-4.42M
-5.71M
Net profit margin
-1,643.15%
370.58%
-316.61%
-417.92%
Earnings per share
-14.17
-0.16
-1.00
-
Interest and investment income
1.00K
27.00K
59.00K
29.00K
Interest expense
-548.00K
-
-
-
Net interest expenses
-547.00K
27.00K
59.00K
29.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.39M
-1.46M
-4.40M
-5.60M
Gain or loss from assets sale
-16.00K
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer